Glaucoma is a multifactorial disease with progressive optic neuropathy and one of the most common causes of blindness worldwide1,2. Various factors have been identified that contribute to pathogenesis of glaucoma - including structural vulnerability of the lamina cribrosa, impaired ocular perfusion, genetics and autoimmune processes - but the only modifiable risk factor remains elevated intraocular pressure (IOP)3,4,5,6,7,8. The most common subtype, primary open-angle glaucoma (POAG), is characterized by an increased outflow resistance leading to a reduced outflow of aqueous humor and thus to a long-term increase in IOP9. This leads to retinal nerve fiber loss and to visual field defects as the disease progresses.
Several treatment strategies are available, which are selected depending on the severity and duration of glaucoma and the measured IOP. If topical IOP-lowering therapy with eye drops is not effective or not tolerated by the patient, laser procedures or surgical interventions can be performed10,11. In addition to traditional filtering surgeries such as trabeculectomy, there are now a variety of lower-risk minimally invasive glaucoma surgeries (MIGS)12. These include ab- interno canaloplasty (AbiC), which, in contrast to ab-externo canaloplasty, does not require an incision of the sclera or the creation of a flap13. The ab-interno approach offers a significantly less invasive procedure in which no suture is left behind as foreign material. It has also been shown that the effect corresponds to that of the ab-externo approach, with significantly simpler handling and fewer complications14,15. An additional advantage of AbiC is that the conjunctival tissue is preserved for future interventions, if necessary.
In this procedure, after assessing the anterior chamber via a corneal incision, a microcatheter is inserted into the Schlemm's canal with the aid of a gonioscope, incising the trabecular meshwork and passing through it in a 360° circle. A viscoelastic expands Schlemm's canal and the ostiae of the collector channels and may induce focal micro ruptures of the trabecular meshwork16. These effects are thought to facilitate aqueous humor outflow by reducing resistance within the conventional outflow pathway, in accordance with the anatomy and physiology of the eye and by improving access to the collector channels, although the exact mechanisms are not yet fully understood17. Furthermore, AbiC can be combined with cataract surgery, which provides an additional IOP reduction. In this context, intraoperative visualization of the outflow pathways may provide indirect information about the functional state of the trabecular meshwork and distal outflow system.
The ab-externo canaloplasty has already been combined with intraoperative channelography with fluorescein to visualize the outflow pathways18,19,20. Eyes with more stained areas of the sclera and thus improved aqueous humor outflow showed a lower IOP one year after the procedure. Intraoperative channelography can therefore be used to predict the effect of the surgery19. To our knowledge, whether this also applies to AbiC has not yet been investigated. The aim of this study is therefore to evaluate a workflow for analyzing intraoperative channelography during AbiC. We developed this workflow to quantify the intensity and extent of subconjunctival fluorescein staining in an early and a late phase. This is the first evaluation of the effect of fluoresceinated viscoelastic in AbiC.
Subsequently, it can be investigated whether there is a correlation between the quantification of the stained areas and the extent of the individual aqueous humor outflow as well as the reduction of the IOP or IOP-lowering medication used postoperatively. It is hypothesized that a stronger staining and thus visibly higher aqueous humor outflow would also mean a greater reduction in IOP and medication use. Division into quadrants will be used to test whether the outflow is significantly altered depending on the anatomical localization.
In the long term, the presented workflow will be used to clarify whether the success of AbiC can be predicted on the basis of staining with fluorescein and can also be used for other necessary surgical treatments.